Trial intelligence / Profile preview

Tenofovir disoproxil fumarate intervention during pregnancy for women with high hepatitis B viral load

ChiCTR1900022889Phase 4Recruiting

Sponsor
Beijing YouAn Hospital
Start
Jan 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB) (2 arms), sponsored by Beijing YouAn Hospital. Primary endpoint: Rate of mother-to-child transmission. Started Jan 2017; status: recruiting.

02

Drugs

tenofovir disoproxil fumarate
03

Conditions

Chronic Hepatitis B (CHB)

Beyond the preview

Go deeper on ChiCTR1900022889.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900022889.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call